Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc
May 12, 2021
Abbott’s New Artificial Intelligence OCT Coronary Imaging Platform Launches in Europe
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has…
Read More
According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.
May 12, 2021
Using Contrast MRI After a Heart Attack Could Increase Survival
May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27…
Read More
Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases.
May 12, 2021
Low Profile Thoracic Aortic Endograft Device Reduces Complications and Expands Patient Pool
May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a…
Read More
EP lab at the University of Colorado
May 12, 2021
Pulsed Electric Field Focal Ablation Catheter From Galaxy Medical and Japan Life Will Seek FDA Clearance 
May 12, 2021 — Galaxy Medical and Japan Lifeline announced an exclusive distribution agreement for the Alpha1 ablation…
Read More
The digital technology is reducing reliance on unnecessary invasive diagnostic procedures and is cutting hospital waiting times
May 12, 2021
NICE Renews Support for Use of AI-powered HeartFlow Analysis
May 12, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National…
Read More
The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial.
By Simon H. Stertzer, M.D.
May 11, 2021
Is Cardiac Cell Therapy Worth Another Look?
Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections…
Read More
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
May 11, 2021
Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (…
Read More
Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease or cardiovascular risk factors, a new Mount Sinai study shows. 
May 11, 2021
Patients Hospitalized With COVID-19 Have a Small Risk of Heart Failure
May 11, 2021 — Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have…
Read More
The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. #wearables
May 10, 2021
Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices
May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College…
Read More
The Eko digital stethoscope can record heart soubnds and use an artificial intelligence  (AI) analysis algorithm to detect heart murmurs. I new study in the JAHA showed it has comparable performance to that of an expert cardiologist. Eko Digital Stethoscope AI Analysis Algorithm Validated in JAHA article for Detecting Heart Murmurs
May 10, 2021
Eko Digital Stethoscope AI Analysis Algorithm Validated for Detecting Heart Murmurs
May 10, 2021 — Eko announced the peer-reviewed publication of a clinical study that found that the Eko artificial…
Read More
An example of a patch type cardiac monitor from Vital Connect. These types of inexpensive, stick-on wearable monitors have seen a tremendous increase in use over the past few years, replacing traditional Holter monitors.
May 06, 2021
Wearable Cardiac Devices Market Will See Rapid Expansion in Coming Years
May 6, 2021 — The wearable cardiac devices market is set to grow from its current market was valued at more than $1.2…
Read More
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021
By Dave Fornell, Editor
May 06, 2021
SCAI 2021 Late-breaking Clinical Study Results
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from…
Read More
The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 
May 06, 2021
Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of…
Read More
The Corindus CorPath robotic cath lab navigation system allows operators to sit and control the procedure from behind a lead-lined booth, so they do not have to wear heavy aprons during the procedures.  Christoper Baker, M.D., Hoag Memorial Hospital using the system. #SCAI21 #SCAI2021
May 05, 2021
Second Generation Robotic PCI System Performs Well Across Spectrum of Lesion Complexity
May 5, 2021 — A late-breaking study of the Siemens Healthineers Corindus Corpath GRX second-generation cath lab robotic…
Read More
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.
May 05, 2021
Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores
May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI)…
Read More
A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure.
May 04, 2021
Similar Long-Term Outcomes With and Without ECMO for Mechanically Ventilated COVID-19 Patients
May 4, 2021 – A new study, presented today at the 2021 American Association for Thoracic Surgery (AATS) 101st annual…
Read More
If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021
May 04, 2021
If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement
May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting…
Read More
8 Essential Steps for a Successful cardiovascular information system (CVIS) or PACS Implementation. Getty Images
By Jef Williams
May 04, 2021
8 Essential Steps for a Successful CVIS or PACS Implementation
You have selected a vendor for your new cardiovascular information system (CVIS) or PACS. Congratulations. Most likely…
Read More
One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial infarction (STEMI), according to the latest, comprehensive data from The North American COVID-19 Myocardial Infarction (NACMI) Registry. The data was presented as a late-breaking study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. The study showed there was an alarming one-in-three patients dying with STEMI and COVID, compared to 4-in-100 #SCAI2021
By Dave Fornell, Editor
May 03, 2021
Third of COVID Patients With STEMI Heart Attacks Die
May 3, 2021 – One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial…
Read More
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images
May 03, 2021
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now